首页> 美国卫生研究院文献>PLoS Clinical Trials >Metabolomic Profiling from Formalin-Fixed, Paraffin-Embedded Tumor Tissue Using Targeted LC/MS/MS: Application in Sarcoma
【2h】

Metabolomic Profiling from Formalin-Fixed, Paraffin-Embedded Tumor Tissue Using Targeted LC/MS/MS: Application in Sarcoma

机译:使用靶向LC / MS / MS从福尔马林固定,石蜡包埋的肿瘤组织进行代谢组学谱分析:在肉瘤中的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The relatively new field of onco-metabolomics attempts to identify relationships between various cancer phenotypes and global metabolite content. Previous metabolomics studies utilized either nuclear magnetic resonance spectroscopy or gas chromatography/mass spectrometry, and analyzed metabolites present in urine and serum. However, direct metabolomic assessment of tumor tissues is important for determining altered metabolism in cancers. In this respect, the ability to obtain reliable data from archival specimens is desirable and has not been reported to date. In this feasibility study, we demonstrate the analysis of polar metabolites extracted directly from ten formalin-fixed, paraffin-embedded (FFPE) specimens, including five soft tissue sarcomas and five paired normal samples. Using targeted liquid chromatography-tandem mass spectrometry (LC/MS/MS) via selected reaction monitoring (SRM), we detect an average of 106 metabolites across the samples with excellent reproducibility and correlation between different sections of the same specimen. Unsupervised hierarchical clustering and principal components analysis reliably recovers a priori known tumor and normal tissue phenotypes, and supervised analysis identifies candidate metabolic markers supported by the literature. In addition, we find that diverse biochemical processes are well-represented in the list of detected metabolites. Our study supports the notion that reliable and broadly informative metabolomic data may be acquired from FFPE soft tissue sarcoma specimens, a finding that is likely to be extended to other malignancies.
机译:肿瘤代谢组学的一个相对较新的领域试图确定各种癌症表型与整体代谢产物含量之间的关系。先前的代谢组学研究利用核磁共振波谱或气相色谱/质谱法,并分析了尿液和血清中存在的代谢物。然而,对肿瘤组织的直接代谢组学评估对于确定癌症中新陈代谢的改变很重要。在这方面,从档案标本中获得可靠数据的能力是人们所希望的,并且迄今尚未见报道。在此可行性研究中,我们证明了从10个福尔马林固定,石蜡包埋(FFPE)标本中直接提取的极性代谢物的分析,其中包括5个软组织肉瘤和5个配对的正常样品。通过选择的反应监测(SRM),使用靶向液相色谱-串联质谱(LC / MS / MS),我们检测了样品中平均106种代谢物,并且同一样品的不同部分之间具有出色的重现性和相关性。无监督的分级聚类和主成分分析可靠地恢复了先验已知的肿瘤和正常组织的表型,并且有监督的分析确定了文献支持的候选代谢标记。此外,我们发现检测到的代谢物列表中充分体现了多种生化过程。我们的研究支持以下观点:可以从FFPE软组织肉瘤样本中获得可靠且信息广泛的代谢组学数据,这一发现可能会扩展到其他恶性肿瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号